环球医疗器械 GMED
$71.05 −$10.39 (-12.76%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $71.20 +0.21%
开盘$74.10
昨收$81.44
当日区间$70.40 – $75.63
成交量9.27M
市值$9.41B
市盈率（TTM）17.5
股息率–
财报
财报日平均波动±8.2%近16次财报
收涨次数10 / 1663% 的概率
最佳反应+35.9%
最差反应-23.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±10.1% | +1.57% | 符合区间 |
| 2026/Q1 | 7 May 2026 | After Market | ±12.1% | -8.37% | 符合区间 |
| 2025/Q4 | 24 Feb 2026 | After Market | ±10.1% | +4.72% | 符合区间 |
| 2025/Q3 | 6 Nov 2025 | After Market | ±12.1% | +35.94% | 超出定价预期 |
| 2025/Q2 | 7 Aug 2025 | After Market | ±9.5% | +8.47% | 符合区间 |
| 2025/Q1 | 8 May 2025 | After Market | ±8.7% | -22.96% | 超出定价预期 |
| 2024/Q4 | 20 Feb 2025 | After Market | ±11.7% | -4.56% | 符合区间 |
| 2024/Q3 | 5 Nov 2024 | After Market | ±9.1% | +9.43% | 超出定价预期 |
| 2024/Q2 | 6 Aug 2024 | After Market | ±8.2% | +2.14% | 符合区间 |
| 2024/Q1 | 7 May 2024 | After Market | ±6.6% | +20.19% | 超出定价预期 |
| 2023/Q4 | 20 Feb 2024 | After Market | ±8.6% | +1.55% | 符合区间 |
| 2023/Q3 | 7 Nov 2023 | After Market | ±9.2% | -0.69% | 符合区间 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±4.4% | -1.87% | 符合区间 |
| 2023/Q1 | 4 May 2023 | After Market | ±7.6% | +3.29% | 符合区间 |
| 2022/Q4 | 21 Feb 2023 | After Market | ±7.5% | +0.51% | 符合区间 |
| 2022/Q3 | 8 Nov 2022 | After Market | ±6.6% | -4.20% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$789.61M+5.9% YoY
营业利润$195.47M+59.2% YoY
净利润$151.57M-25.3% YoY
摊薄每股收益$1.10-26.2% YoY
自由现金流$176.57M+464.1% YoY
经营现金流$209.74M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率68.5%
营业利润率21.4%
净利率17.0%
净资产收益率11.8%
资产收益率10.2%
投入资本回报率11.5%
流动比率4.62
负债/资产比率13.1%
现金及投资$595.14M
总负债$96.81M
净现金（净负债）$498.34M
自由现金流/营收23.7%
暂无评论——快来第一个聊聊 GMED。